Skip to main content
OpenTrials

Clinical trial condition

NSCLC Stage IIIB

Explore clinical trials studying NSCLC Stage IIIB. Study availability and eligibility vary by location and protocol.

9 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

NSCLC Stage IIIB trial results

Recruiting

Additional Chemotherapy for EGFRm Patients with the Continued Presence of Plasma CtDNA EGFRm At Week 3 After Start of Osimertinib 1st-line Treatment (PACE-LUNG)

NCT05281406

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Charité Universitätsmedizin Berlin Campus Virchow Klinikum Klinik mit Schwerpunkt Infektiologie und Pneumologie Berlin, Germany
  • Universitätsklinik Köln, Lung Cancer Group Cologne - Innere Medizin I Cologne, Germany
  • Technische Universität Dresden Medizinische Fakultät Carl Gustav Carus Medizinische Klinik und Poliklinik I Dresden, Germany
  • Universitätsklinikum Essen, Westdeutsches Tumorzentrum - Innere Klinik Essen, Germany
View all 16 locations
View Trial Details
Completed

A Study Evaluating Platinum-Pemetrexed-Atezolizumab (+/-Bevacizumab) for Patients With Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer With EGFR Mutations, ALK Rearrangement or ROS1 Fusion Progressing After Targeted Therapies

NCT04042558

Conditions
ALK Gene Rearrangement Positive, Bronchial Neoplasms, Carcinoma, Bronchogenic, +12 more
Locations
  • CHU Angers, France
  • Centre Hospitalier Annecy, France
  • CHU-Hôpital MORVAN Brest, France
  • CHU Lyon Louis Pradel Bron, France
View all 31 locations
View Trial Details
Active, Not Recruiting

Clinical Utility of Liquid Biopsy in Brigatinib ALK+ Patients

NCT04223596

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • Complejo Hospitalario de A Coruña A Coruña, Spain
  • Hospital General de Alicante Alicante, Spain
  • Hospital Regional Universitario de Málaga Málaga, Andalusia, Spain
  • Hospital Son Espases Palma de Mallorca, Balearic Islands, Spain
View all 15 locations
View Trial Details
Active, Not Recruiting

1st Line Durvalumab in PS 2 NSCLC Patients

NCT03620669

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Kantonsspital Aarau Aarau, Switzerland
  • Kantonsspital Baden Baden, Switzerland
  • Universitaetsspital Basel Basel, Switzerland
  • IOSI Ospedale Regionale di Bellinzona e Valli Bellinzona, Switzerland
View Trial Details
Active, Not Recruiting

Phase 2 Study of Dacomitinib in NSCLC

NCT04027647

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • Prince of Wales Hospital Hong Kong
  • Sarawak General Hospital Kuching, Sarawak, Malaysia
  • University Malaya Medical Centre Kuala Lumpur, Malaysia
  • Beacon Hospital Petaling Jaya, Malaysia
View Trial Details

Related conditions